When the time was to start developing the innovation to final medical product, Olfactomics chose Innokas Medical to be their co-creation partner.

‍

“We started the process with all major Finnish suppliers involved in the quotation process. Innokas ended up being the most competitive co-creation partner for us because of the company’s modern and agile design and development process, wide competence pool and the references to produce medical devices to the global markets”, Niku Oksala, Chairman of the Board of Directors at Olfactomics says.

‍

An innovation developed by Finnish startup company Olfactomics helps to improve the accuracy of cancer surgeries by allowing rapid, real-time analysis of biological gas mixtures during the surgery. The company focuses on improving breast-conserving lumpectomies, and to save even 100 000 women yearly from unnecessary reoperations or breast removals.